Page last updated: 2024-08-22
niobium and deferoxamine
niobium has been researched along with deferoxamine in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gachályi, A; Naményi, J; Szegedi, I; Varga, PL | 1 |
| Gachályi, A; Naményi, J; Szegedi, I; Varga, LP | 1 |
| Bouziotis, P; Eisenhut, M; Filosofov, D; Harris, AL; Hauser, H; la Fuente, Ad; Loudos, G; Paravatou-Petsotas, M; Ponsard, B; Radchenko, V; Roesch, F; Tsotakos, T; Xanthopoulos, S | 1 |
Other Studies
3 other study(ies) available for niobium and deferoxamine
| Article | Year |
|---|---|
Effect of mixed ligand complex therapy on the retention of 95Nb and 144Ce in mice.
Topics: Animals; Cerium Radioisotopes; Chelating Agents; Decontamination; Deferoxamine; Drug Therapy, Combination; Male; Mice; Niobium; Penicillamine; Pentetic Acid; Radioisotopes | 1989 |
Influence of mixed-ligand complexes on retention and distribution of radioniobium in mice.
Topics: Animals; beta-Aminoethyl Isothiourea; Chelating Agents; Decontamination; Deferoxamine; Drug Therapy, Combination; Male; Mice; Niobium; Penicillamine; Pentetic Acid; Radioisotopes; Sodium Salicylate | 1987 |
Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study.
Topics: Animals; Bevacizumab; Chlorides; Deferoxamine; Drug Stability; Female; Half-Life; Isotope Labeling; Mice; Niobium; Oxalates; Positron-Emission Tomography; Radioisotopes; Tissue Distribution | 2016 |